Indolent Lymphoma Treatment Market - Global Outlook and Forecast 2021-2027

Code: RW00014561104
Market Monitor Global
Oct-2021
Life Sciences
102 Pages

This report contains market size and forecasts of Indolent Lymphoma Treatment in Global, including the following market information:
Global Indolent Lymphoma Treatment Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Indolent Lymphoma Treatment market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Indolent Lymphoma Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Indolent Lymphoma Treatment Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Indolent Lymphoma Treatment Market Segment Percentages, By Type, 2020 (%)
BI-836826
ALT-803
BMS-986016
CC-122
Others

China Indolent Lymphoma Treatment Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Indolent Lymphoma Treatment Market Segment Percentages, By Application, 2020 (%)
Hospital
Clinic
Others

Global Indolent Lymphoma Treatment Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Indolent Lymphoma Treatment Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Indolent Lymphoma Treatment Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Indolent Lymphoma Treatment Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Altor BioScience Corporation
Amgen Inc.
Astellas Pharma Inc.
Bayer AG
Boehringer Ingelheim GmbH
Bristol-Myers Squibb Company
Celgene Corporation
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
Gilead Sciences, Inc.
Incyte Corporation
Infinity Pharmaceuticals, Inc.
Juno Therapeutics Inc.
MedImmune, LLC

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Indolent Lymphoma Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Indolent Lymphoma Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Indolent Lymphoma Treatment Overall Market Size
2.1 Global Indolent Lymphoma Treatment Market Size: 2021 VS 2027
2.2 Global Indolent Lymphoma Treatment Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Indolent Lymphoma Treatment Players in Global Market
3.2 Top Global Indolent Lymphoma Treatment Companies Ranked by Revenue
3.3 Global Indolent Lymphoma Treatment Revenue by Companies
3.4 Top 3 and Top 5 Indolent Lymphoma Treatment Companies in Global Market, by Revenue in 2020
3.5 Global Companies Indolent Lymphoma Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Indolent Lymphoma Treatment Players in Global Market
3.6.1 List of Global Tier 1 Indolent Lymphoma Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Indolent Lymphoma Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Indolent Lymphoma Treatment Market Size Markets, 2021 & 2027
4.1.2 BI-836826
4.1.3 ALT-803
4.1.4 BMS-986016
4.1.5 CC-122
4.1.6 Others
4.2 By Type - Global Indolent Lymphoma Treatment Revenue & Forecasts
4.2.1 By Type - Global Indolent Lymphoma Treatment Revenue, 2016-2021
4.2.2 By Type - Global Indolent Lymphoma Treatment Revenue, 2022-2027
4.2.3 By Type - Global Indolent Lymphoma Treatment Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Indolent Lymphoma Treatment Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Indolent Lymphoma Treatment Revenue & Forecasts
5.2.1 By Application - Global Indolent Lymphoma Treatment Revenue, 2016-2021
5.2.2 By Application - Global Indolent Lymphoma Treatment Revenue, 2022-2027
5.2.3 By Application - Global Indolent Lymphoma Treatment Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Indolent Lymphoma Treatment Market Size, 2021 & 2027
6.2 By Region - Global Indolent Lymphoma Treatment Revenue & Forecasts
6.2.1 By Region - Global Indolent Lymphoma Treatment Revenue, 2016-2021
6.2.2 By Region - Global Indolent Lymphoma Treatment Revenue, 2022-2027
6.2.3 By Region - Global Indolent Lymphoma Treatment Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Indolent Lymphoma Treatment Revenue, 2016-2027
6.3.2 US Indolent Lymphoma Treatment Market Size, 2016-2027
6.3.3 Canada Indolent Lymphoma Treatment Market Size, 2016-2027
6.3.4 Mexico Indolent Lymphoma Treatment Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Indolent Lymphoma Treatment Revenue, 2016-2027
6.4.2 Germany Indolent Lymphoma Treatment Market Size, 2016-2027
6.4.3 France Indolent Lymphoma Treatment Market Size, 2016-2027
6.4.4 U.K. Indolent Lymphoma Treatment Market Size, 2016-2027
6.4.5 Italy Indolent Lymphoma Treatment Market Size, 2016-2027
6.4.6 Russia Indolent Lymphoma Treatment Market Size, 2016-2027
6.4.7 Nordic Countries Indolent Lymphoma Treatment Market Size, 2016-2027
6.4.8 Benelux Indolent Lymphoma Treatment Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Indolent Lymphoma Treatment Revenue, 2016-2027
6.5.2 China Indolent Lymphoma Treatment Market Size, 2016-2027
6.5.3 Japan Indolent Lymphoma Treatment Market Size, 2016-2027
6.5.4 South Korea Indolent Lymphoma Treatment Market Size, 2016-2027
6.5.5 Southeast Asia Indolent Lymphoma Treatment Market Size, 2016-2027
6.5.6 India Indolent Lymphoma Treatment Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Indolent Lymphoma Treatment Revenue, 2016-2027
6.6.2 Brazil Indolent Lymphoma Treatment Market Size, 2016-2027
6.6.3 Argentina Indolent Lymphoma Treatment Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Indolent Lymphoma Treatment Revenue, 2016-2027
6.7.2 Turkey Indolent Lymphoma Treatment Market Size, 2016-2027
6.7.3 Israel Indolent Lymphoma Treatment Market Size, 2016-2027
6.7.4 Saudi Arabia Indolent Lymphoma Treatment Market Size, 2016-2027
6.7.5 UAE Indolent Lymphoma Treatment Market Size, 2016-2027
7 Players Profiles
7.1 Altor BioScience Corporation
7.1.1 Altor BioScience Corporation Corporate Summary
7.1.2 Altor BioScience Corporation Business Overview
7.1.3 Altor BioScience Corporation Indolent Lymphoma Treatment Major Product Offerings
7.1.4 Altor BioScience Corporation Indolent Lymphoma Treatment Revenue in Global (2016-2021)
7.1.5 Altor BioScience Corporation Key News
7.2 Amgen Inc.
7.2.1 Amgen Inc. Corporate Summary
7.2.2 Amgen Inc. Business Overview
7.2.3 Amgen Inc. Indolent Lymphoma Treatment Major Product Offerings
7.2.4 Amgen Inc. Indolent Lymphoma Treatment Revenue in Global (2016-2021)
7.2.5 Amgen Inc. Key News
7.3 Astellas Pharma Inc.
7.3.1 Astellas Pharma Inc. Corporate Summary
7.3.2 Astellas Pharma Inc. Business Overview
7.3.3 Astellas Pharma Inc. Indolent Lymphoma Treatment Major Product Offerings
7.3.4 Astellas Pharma Inc. Indolent Lymphoma Treatment Revenue in Global (2016-2021)
7.3.5 Astellas Pharma Inc. Key News
7.4 Bayer AG
7.4.1 Bayer AG Corporate Summary
7.4.2 Bayer AG Business Overview
7.4.3 Bayer AG Indolent Lymphoma Treatment Major Product Offerings
7.4.4 Bayer AG Indolent Lymphoma Treatment Revenue in Global (2016-2021)
7.4.5 Bayer AG Key News
7.5 Boehringer Ingelheim GmbH
7.5.1 Boehringer Ingelheim GmbH Corporate Summary
7.5.2 Boehringer Ingelheim GmbH Business Overview
7.5.3 Boehringer Ingelheim GmbH Indolent Lymphoma Treatment Major Product Offerings
7.5.4 Boehringer Ingelheim GmbH Indolent Lymphoma Treatment Revenue in Global (2016-2021)
7.5.5 Boehringer Ingelheim GmbH Key News
7.6 Bristol-Myers Squibb Company
7.6.1 Bristol-Myers Squibb Company Corporate Summary
7.6.2 Bristol-Myers Squibb Company Business Overview
7.6.3 Bristol-Myers Squibb Company Indolent Lymphoma Treatment Major Product Offerings
7.6.4 Bristol-Myers Squibb Company Indolent Lymphoma Treatment Revenue in Global (2016-2021)
7.6.5 Bristol-Myers Squibb Company Key News
7.7 Celgene Corporation
7.7.1 Celgene Corporation Corporate Summary
7.7.2 Celgene Corporation Business Overview
7.7.3 Celgene Corporation Indolent Lymphoma Treatment Major Product Offerings
7.4.4 Celgene Corporation Indolent Lymphoma Treatment Revenue in Global (2016-2021)
7.7.5 Celgene Corporation Key News
7.8 Eli Lilly and Company
7.8.1 Eli Lilly and Company Corporate Summary
7.8.2 Eli Lilly and Company Business Overview
7.8.3 Eli Lilly and Company Indolent Lymphoma Treatment Major Product Offerings
7.8.4 Eli Lilly and Company Indolent Lymphoma Treatment Revenue in Global (2016-2021)
7.8.5 Eli Lilly and Company Key News
7.9 F. Hoffmann-La Roche Ltd.
7.9.1 F. Hoffmann-La Roche Ltd. Corporate Summary
7.9.2 F. Hoffmann-La Roche Ltd. Business Overview
7.9.3 F. Hoffmann-La Roche Ltd. Indolent Lymphoma Treatment Major Product Offerings
7.9.4 F. Hoffmann-La Roche Ltd. Indolent Lymphoma Treatment Revenue in Global (2016-2021)
7.9.5 F. Hoffmann-La Roche Ltd. Key News
7.10 Gilead Sciences, Inc.
7.10.1 Gilead Sciences, Inc. Corporate Summary
7.10.2 Gilead Sciences, Inc. Business Overview
7.10.3 Gilead Sciences, Inc. Indolent Lymphoma Treatment Major Product Offerings
7.10.4 Gilead Sciences, Inc. Indolent Lymphoma Treatment Revenue in Global (2016-2021)
7.10.5 Gilead Sciences, Inc. Key News
7.11 Incyte Corporation
7.11.1 Incyte Corporation Corporate Summary
7.11.2 Incyte Corporation Business Overview
7.11.3 Incyte Corporation Indolent Lymphoma Treatment Major Product Offerings
7.11.4 Incyte Corporation Indolent Lymphoma Treatment Revenue in Global (2016-2021)
7.11.5 Incyte Corporation Key News
7.12 Infinity Pharmaceuticals, Inc.
7.12.1 Infinity Pharmaceuticals, Inc. Corporate Summary
7.12.2 Infinity Pharmaceuticals, Inc. Business Overview
7.12.3 Infinity Pharmaceuticals, Inc. Indolent Lymphoma Treatment Major Product Offerings
7.12.4 Infinity Pharmaceuticals, Inc. Indolent Lymphoma Treatment Revenue in Global (2016-2021)
7.12.5 Infinity Pharmaceuticals, Inc. Key News
7.13 Juno Therapeutics Inc.
7.13.1 Juno Therapeutics Inc. Corporate Summary
7.13.2 Juno Therapeutics Inc. Business Overview
7.13.3 Juno Therapeutics Inc. Indolent Lymphoma Treatment Major Product Offerings
7.13.4 Juno Therapeutics Inc. Indolent Lymphoma Treatment Revenue in Global (2016-2021)
7.13.5 Juno Therapeutics Inc. Key News
7.14 MedImmune, LLC
7.14.1 MedImmune, LLC Corporate Summary
7.14.2 MedImmune, LLC Business Overview
7.14.3 MedImmune, LLC Indolent Lymphoma Treatment Major Product Offerings
7.14.4 MedImmune, LLC Indolent Lymphoma Treatment Revenue in Global (2016-2021)
7.14.5 MedImmune, LLC Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Indolent Lymphoma Treatment Market Opportunities & Trends in Global Market
Table 2. Indolent Lymphoma Treatment Market Drivers in Global Market
Table 3. Indolent Lymphoma Treatment Market Restraints in Global Market
Table 4. Key Players of Indolent Lymphoma Treatment in Global Market
Table 5. Top Indolent Lymphoma Treatment Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Indolent Lymphoma Treatment Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Indolent Lymphoma Treatment Revenue Share by Companies, 2016-2021
Table 8. Global Companies Indolent Lymphoma Treatment Product Type
Table 9. List of Global Tier 1 Indolent Lymphoma Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Indolent Lymphoma Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

Altor BioScience Corporation
Amgen Inc.
Astellas Pharma Inc.
Bayer AG
Boehringer Ingelheim GmbH
Bristol-Myers Squibb Company
Celgene Corporation
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
Gilead Sciences, Inc.
Incyte Corporation
Infinity Pharmaceuticals, Inc.
Juno Therapeutics Inc.
MedImmune, LLC

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE